Skip to content

Which is better treatment option for when we give vitamin D3 with methyl prednisolone injection OR when we give methyl prednisolone alone in patients with nerve compression of wrist

Evaluation of efficacy and safety of oral vitamin-D3 as an add on therapy to intracarpal injection of methyl prednisolone in the management of carpal tunnel syndrome: An open labelled prospective study - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/069099
Enrollment
105
Registered
2024-06-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G560- Carpal tunnel syndrome Health Condition 2: E559- Vitamin D deficiency, unspecified

Interventions

Intervention1: Vitamin D3 Orally 60,000 IU once weekly for 12 weeks + single intracarpal injection of methyl prednisolone 40 mg stat: Intervention groups A & B will have 35 patients in each and receiv

Sponsors

Bhagat Phool Singh Govt. Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Mild and moderate cases of Carpal Tunnel Syndrome of age group between 18 and 60 yrs with serum vitamin D levels of greater than or equal to 10 ng/ml and with BMI more than 30 Kg/m2. 2. Patients who are willing to give written informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Patients with severe CTS. 2. Patients who are having severe vitamin-D deficiency (less than 10ng/ml) and patients who are already on vitamin D3 supplement since 1 year. 3. Patients with history of existing wrist deformity, wrist disease, trauma, obesity, metabolic diseases such as diabetes, thyroid disorder, rheumatoid arthritis, chronic liver disease, chronic renal disease, congenital or acquired polyneuropathy and hypersensitivity to any of the studydrugs or any contraindication to any drug involved in this study. 4. Pregnancy and lactation. 5. History of previous CTS release surgery or local corticosteroid injections. 6. Patients who are not willing to give consent.

Design outcomes

Primary

MeasureTime frame
Nerve Conduction Test, Boston Carpal Tunnel Questionnaire, quick DASH questionnaire, Visual Analogue Scale, Serum vitamin D.Timepoint: 0, 4, 8 and 12 weeks

Secondary

MeasureTime frame
Patient’s satisfactionTimepoint: 4, 8 and 12 week

Countries

India

Contacts

Public ContactDr Gollu Sarada

BPS GMC (W), Khanpur Kalan

seema17march@gmail.com9466359666

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026